The Diabetes National Clinical Network has issued updated HbA1c diagnostic thresholds to align New Zealand reporting with global standards and to support improved patient outcomes.
HbA1c result flagging will occur if the result is 42 mmol/mol or above (currently this is 40 mmol/mol). In addition, explanatory comments will be added depending on the HbA1c result (as provided by the Diabetes National Clinical Network).
The above changes were implemented by Pathlab on Wednesday 22 April, ahead of the Ministry of Health deadline of 1 July 2026.
See the Pathlab test website for a complete list of HbA1c levels and applicable comment.
This week the Pinnacle Incorporated Executive Committee has written to Dr Ashley Bloomfield, Director-General of Health and Labour MPs across the Midland region asking them to reconsider lowering the screening age for Māori and Pacific people.
Read morePathlab is changing its coeliac disease testing algorithm and will no longer perform upfront total IgA testing on all coeliac requests. From 11 November 2025, total IgA will only be added when results suggest possible IgA deficiency, with anti-DGP IgG continuing to be added automatically when IgA is <0.05 g/L. This updated approach aligns with published evidence and current practice at Canterbury Health Laboratories.
Read moreThe B4 School Check (B4SC) is a universal, comprehensive check for all four-year-old’s that includes height and weight, vision and hearing, immunisations, oral health, and behavioral and developmental components.
View detailsNational Cervical Screening Programme screening updates.